David O. Watson, General Counsel at Apellis Pharmaceuticals, Inc. (APLS), sold 4,402 shares at $29.96 ($132K) on 2025-01-17, disclosed to the SEC on 2025-01-21.
Seasonal sale ($132k) by General Counsel — this insider has traded APLS in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.96 | 2,201 | $66K | 50.0% |
| 2 | $29.96 | 2,201 | $66K | 50.0% |
| Total | $29.96 avg | 4,402 | $132K | 100% |
| Filing → |
| APLS | SELL | 2026-01-15 | $128K | — | Filing → |
| APLS | SELL | 2025-12-18 | $245K | — | Filing → |
| APLS | SELL | 2025-11-18 | $100K | — | Filing → |